1. Home
  2. LIXT vs CNET Comparison

LIXT vs CNET Comparison

Compare LIXT & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • CNET
  • Stock Information
  • Founded
  • LIXT 2005
  • CNET 2003
  • Country
  • LIXT United States
  • CNET China
  • Employees
  • LIXT N/A
  • CNET N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • CNET Advertising
  • Sector
  • LIXT Health Care
  • CNET Consumer Discretionary
  • Exchange
  • LIXT Nasdaq
  • CNET Nasdaq
  • Market Cap
  • LIXT 4.2M
  • CNET 4.2M
  • IPO Year
  • LIXT N/A
  • CNET N/A
  • Fundamental
  • Price
  • LIXT $1.62
  • CNET $1.64
  • Analyst Decision
  • LIXT
  • CNET
  • Analyst Count
  • LIXT 0
  • CNET 0
  • Target Price
  • LIXT N/A
  • CNET N/A
  • AVG Volume (30 Days)
  • LIXT 1.8M
  • CNET 75.1K
  • Earning Date
  • LIXT 11-12-2024
  • CNET 11-29-2024
  • Dividend Yield
  • LIXT N/A
  • CNET N/A
  • EPS Growth
  • LIXT N/A
  • CNET N/A
  • EPS
  • LIXT N/A
  • CNET N/A
  • Revenue
  • LIXT N/A
  • CNET $24,400,000.00
  • Revenue This Year
  • LIXT N/A
  • CNET N/A
  • Revenue Next Year
  • LIXT N/A
  • CNET N/A
  • P/E Ratio
  • LIXT N/A
  • CNET N/A
  • Revenue Growth
  • LIXT N/A
  • CNET N/A
  • 52 Week Low
  • LIXT $1.31
  • CNET $1.60
  • 52 Week High
  • LIXT $4.42
  • CNET $5.04
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 43.04
  • CNET 40.44
  • Support Level
  • LIXT $1.56
  • CNET $1.60
  • Resistance Level
  • LIXT $1.87
  • CNET $2.18
  • Average True Range (ATR)
  • LIXT 0.23
  • CNET 0.27
  • MACD
  • LIXT -0.03
  • CNET 0.00
  • Stochastic Oscillator
  • LIXT 8.33
  • CNET 5.06

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

Share on Social Networks: